| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/28/2001 | EP1087230A1 Method for identifying compounds useful in the therapy of bone disorders |
| 03/28/2001 | EP1087014A1 Hog cholera virus vaccine and diagnostic |
| 03/28/2001 | EP1087013A2 Immunoglobulins devoid of light chains |
| 03/28/2001 | EP1086950A1 Heterocyclic indole derivatives and mono- or diazaindole derivatives |
| 03/28/2001 | EP1086947A1 Somatostatin antagonists and agonists that act at the SST subtype 2 receptor |
| 03/28/2001 | EP1086700A2 A solid pharmaceutical composition for dialysate containing sodium bicarbonate and a process for producing the same |
| 03/28/2001 | EP1086682A2 Utilization of aryl(or heteroaryl)azolylcarbinol derivatives in the preparation of a medicament for the treatment of neurogenic inflammation |
| 03/28/2001 | EP1086249A2 Diagnostic method based on quantification of extramitochondrial dna |
| 03/28/2001 | EP1086238A1 Human mp52 gene promoter and method for exploring useful substance by using the same |
| 03/28/2001 | EP1086234A1 New human carboxypeptidase inhibitor |
| 03/28/2001 | EP1086232A1 A vaccine-induced hepatitis b viral strain and uses thereof |
| 03/28/2001 | EP1086222A2 Cell cycle regulation proteins |
| 03/28/2001 | EP1086219A2 Proteins regulating gene expression |
| 03/28/2001 | EP1086217A2 Novel angiotensin receptor, production and use thereof |
| 03/28/2001 | EP1086212A2 Method and reagents for the treatment of diseases or conditions related to molecules involved in angiogenic responses |
| 03/28/2001 | EP1086136A1 Monoclonal antibodies specific for guanidino group-derived advanced glycosylation endproducts in biological samples |
| 03/28/2001 | EP1086131A1 Cyclic somatostatin analogs |
| 03/28/2001 | EP1086129A1 Anti-angiogenic proteins and methods of use thereof |
| 03/28/2001 | EP1086124A1 Novel cyclosporins |
| 03/28/2001 | EP1086108A1 Heterobicyclic and tricyclic nitric oxide synthase inhibitors |
| 03/28/2001 | EP1086106A1 Furopyridine derivatives and their therapeutical use |
| 03/28/2001 | EP1086105A1 Fused azepinone cyclin dependent kinase inhibitors |
| 03/28/2001 | EP1086103A1 Pyrido 2,3-b]indolizine derivatives and aza analogues thereof; crf 1? specific ligands |
| 03/28/2001 | EP1086102A1 Acetylcholine enhancers |
| 03/28/2001 | EP1086101A1 Beta-carboline compounds |
| 03/28/2001 | EP1086100A1 Pyrrole derivatives, preparation method and pharmaceutical compositions containing same |
| 03/28/2001 | EP1086098A1 Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists |
| 03/28/2001 | EP1086097A1 Sulfonylbenzene compounds as anti-inflammatory/analgesic agents |
| 03/28/2001 | EP1086096A1 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors |
| 03/28/2001 | EP1086095A1 Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors |
| 03/28/2001 | EP1086093A1 Tetrahydroquinoline derivatives as glycine antagonists |
| 03/28/2001 | EP1086091A1 Hiv integrase inhibitors |
| 03/28/2001 | EP1086088A2 Novel neurokinin antagonists, method for the production thereof and pharmaceutical compositions containing said compounds |
| 03/28/2001 | EP1086086A1 Imidazolyl derivatives and their use as somatostatin receptor ligands |
| 03/28/2001 | EP1086084A1 Tetraisoquinololine derivatives as modulators of dopamine d3 receptors |
| 03/28/2001 | EP1086083A1 Protease inhibitors |
| 03/28/2001 | EP1086071A1 Hyperforin derivatives, the use thereof and formulations containing them |
| 03/28/2001 | EP1086066A1 Muscarinic receptor antagonists |
| 03/28/2001 | EP1086063A1 Novel potassium channel drugs and their uses |
| 03/28/2001 | EP1085909A2 Composition for the treatement of immune deficiencies and methods for its preparation and use |
| 03/28/2001 | EP1085901A2 Use of secretin for the treatment of autism and other neurological, behavioral and immunological disorders |
| 03/28/2001 | EP1085896A1 Conformationally constrained backbone cyclized somatostatin analogs |
| 03/28/2001 | EP1085895A1 Bradykinin antagonists |
| 03/28/2001 | EP1085894A1 Beta 3-adrenergic receptor agonists |
| 03/28/2001 | EP1085893A1 Phosphodiesterase-v modulator drugs and their uses |
| 03/28/2001 | EP1085891A1 Multibinding inhibitors of topoisomerase |
| 03/28/2001 | EP1085890A1 Novel sodium channel drugs and uses |
| 03/28/2001 | EP1085889A2 Novel therapeutic agents that modulate endothelin receptors |
| 03/28/2001 | EP1085887A2 Novel angiotensin receptor modulators and their uses |
| 03/28/2001 | EP1085886A1 Protecting neurons from ischemia |
| 03/28/2001 | EP1085882A2 Use of genetically engineered antibodies to cd38 to treat multiple myeloma |
| 03/28/2001 | EP1085880A2 Use of alkylating compounds for inhibiting proliferation of arterial smooth muscle cells |
| 03/28/2001 | EP1085879A2 Multibinding agents that modulate the 5-ht transporter |
| 03/28/2001 | EP1085878A2 Use of aminosterol derivatives as chloride ionophores |
| 03/28/2001 | EP1085876A1 Pharmaceutical composition with tumor necrosis factor a and 2-methoxyestrone-3-o-sulphamate for inhibition of estrone sulphatase |
| 03/28/2001 | EP1085875A1 Use of a nk-1 receptor antagonist for treating psychiatric disorders |
| 03/28/2001 | EP1085873A1 Use of a nk-1 receptor antagonist for treating psychiatric disorders |
| 03/28/2001 | EP1085871A1 QUINAZOLINONE INHIBITORS OF cGMP PHOSPHODIESTERASE |
| 03/28/2001 | EP1085870A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 03/28/2001 | EP1085869A1 Spiropiperidine derivatives as melanocortin receptor agonists |
| 03/28/2001 | EP1085868A1 H1-histamine receptor antagonists |
| 03/28/2001 | EP1085867A1 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty |
| 03/28/2001 | EP1085863A1 Cross-reference to related applications |
| 03/28/2001 | EP1085861A1 Inhibitors of nitric oxide synthase |
| 03/28/2001 | EP1085858A2 Transdermal therapeutic system for the administration of candesartan |
| 03/28/2001 | EP1085854A1 N-linked sulfonamide of heterocyclic thioester hair growth compounds and uses |
| 03/28/2001 | EP1085848A2 Inhibitors of transcription factor nf-kappa b |
| 03/28/2001 | EP1085847A2 Novel therapeutic agents that modulate estrogen receptors |
| 03/28/2001 | EP1085846A2 Multibinding inhibitors of microsomal triglyceride transferase protein |
| 03/28/2001 | EP1085845A2 Multibinding inhibitors of cyclooxygenase-2 |
| 03/28/2001 | EP1085811A1 Broad specificity dna damage endonuclease |
| 03/28/2001 | EP0876330B1 Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4-tetrahydroquinoline carboxylic acids having retinoid-like biological activity |
| 03/28/2001 | EP0775132B1 (azetidin-1-ylalkyl)lactams as tachykinin antagonists |
| 03/28/2001 | EP0767800B1 Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase |
| 03/28/2001 | EP0759087B1 Compositions and methods for targeting gene delivery vehicles |
| 03/28/2001 | EP0721330B1 Pharmaceutical composition |
| 03/28/2001 | CN1289336A Chemokine receptor antagonists and methods of use therefor |
| 03/28/2001 | CN1289335A Azolo triazizes and pyrimidines |
| 03/28/2001 | CN1289334A Benzothiadiazoles and derivatives |
| 03/28/2001 | CN1289333A Oxazole derivatives as serotonin-1A receptor ogonists |
| 03/28/2001 | CN1289332A 1,4-Diazacycloheptane derivatives for the treatment of neurological disorders |
| 03/28/2001 | CN1289331A Farnesyl transferase inhibitors having a piperidine structure and process for preparation thereof |
| 03/28/2001 | CN1289326A N-[(substituted five-membered di-or thiaza diunsaturated ring) carbonyl] guanidine derivatives for the treatment of ischemia |
| 03/28/2001 | CN1289323A Matrix metalloproteinase inhibitors |
| 03/28/2001 | CN1289321A Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament |
| 03/28/2001 | CN1289256A Absorbable microparticles |
| 03/28/2001 | CN1289249A Derivatives of 1,3,4-oxadiazolone |
| 03/28/2001 | CN1288885A Alkylating method of hindered sulfonic acid |
| 03/28/2001 | CN1288731A Slow-releasing concentrated fish oil tablet and its preparation |
| 03/27/2001 | US6207855 Stable no-delivering compounds |
| 03/27/2001 | US6207832 Camptothecin analogs and methods of preparation thereof |
| 03/27/2001 | US6207816 High affinity oligonucleotide ligands to growth factors |
| 03/27/2001 | US6207803 Amino acid sequence of polypeptide; anticarcinogenic agents; antitumor agents; treatment of automimmune disorders, blood disorders; alzheimer's/parkinson's disease, septic shock, osteoporosis, polycystic kidney disease; viricides; diagnosis |
| 03/27/2001 | US6207801 FADD-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same |
| 03/27/2001 | US6207718 Stability |
| 03/27/2001 | US6207700 Aministering carboxylic acid secondary amide derivative containing indole system which is selective for inhibition of cyclooxygenase-2 for cancer therapy in warm blooded vertebrate animal |
| 03/27/2001 | US6207693 Benzamide derivatives having a vasopressin antagonistic activity |
| 03/27/2001 | US6207690 Treating tumor by administering therapeutically effective amount of triglitazone compound |
| 03/27/2001 | US6207686 Endothelin antagonists |
| 03/27/2001 | US6207685 Inhibiting effects of exogenous neurotoxic or neurotoxinic products in warm-blooded animals by administering 2-methyl-1-(1-piperidinyl)-1-(2-thienyl)-cyclohexane in pure racemic, diastereoisomeric or enantiomeric form |